Literature DB >> 26786652

Use of lateral flow assays to determine IP-10 and CCL4 levels in pleural effusions and whole blood for TB diagnosis.

Jayne S Sutherland1, Joseph Mendy2, Awa Gindeh2, Gerhard Walzl3, Toyin Togun2, Olumuyiwa Owolabi2, Simon Donkor2, Martin O Ota2, Elisa Tjon Kon Fat4, Tom H M Ottenhoff4, Annemieke Geluk4, Paul L A M Corstjens5.   

Abstract

One of the key problems in combating TB is the lack of fast and accurate diagnostic tests that are affordable and easy to use in resource-limited settings. We have used a field-friendly up-converting phosphor (UCP) reporter technology in a lateral flow (LF) based test for the diagnosis of respiratory infections. In this study we analysed samples obtained from patients presenting with symptoms suggestive of TB but prior to confirmation by microbiology in The Gambia. Following clinical and microbiological evaluation they were classified as either having TB or other respiratory disorder (ORD). Analysis of blood was performed for those with pulmonary TB and pleural fluid for those with pleural TB. UCP-LF test for detection and quantitation of IP-10 and CCL4 were used being the two chemokine markers that have been shown to increase in active TB disease. UCP-LF test accurately determined concentrations of both markers as compared to ELISA and multiplex cytokine array. However, only IP-10 could discriminate between TB and ORD, and this was significantly enhanced by analysing the site of infection (pleural fluid), which showed 92% correct classification. Future work will assess the use of multiple markers to increase diagnostic accuracy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CCL4; IP10; Pleural TB; Pulmonary TB; Tuberculosis; UCP-LF

Mesh:

Substances:

Year:  2015        PMID: 26786652     DOI: 10.1016/j.tube.2015.10.011

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  13 in total

Review 1.  Inorganic Complexes and Metal-Based Nanomaterials for Infectious Disease Diagnostics.

Authors:  Christine F Markwalter; Andrew G Kantor; Carson P Moore; Kelly A Richardson; David W Wright
Journal:  Chem Rev       Date:  2018-12-04       Impact factor: 60.622

2.  Measuring bovine γδ T cell function at the site of Mycobacterium bovis infection.

Authors:  Rachel A Rusk; Mitchell V Palmer; W Ray Waters; Jodi L McGill
Journal:  Vet Immunol Immunopathol       Date:  2017-10-27       Impact factor: 2.046

3.  Prospective evaluation of host biomarkers other than interferon gamma in QuantiFERON Plus supernatants as candidates for the diagnosis of tuberculosis in symptomatic individuals.

Authors:  Portia M Manngo; Andrea Gutschmidt; Candice I Snyders; Hygon Mutavhatsindi; Charles M Manyelo; Nonjabulo S Makhoba; Petri Ahlers; Andriette Hiemstra; Kim Stanley; Shirley McAnda; Martin Kidd; Stephanus T Malherbe; Gerhard Walzl; Novel N Chegou
Journal:  J Infect       Date:  2019-07-15       Impact factor: 6.072

4.  Field-friendly serological tests for determination of M. leprae-specific antibodies.

Authors:  Anouk van Hooij; Elisa M Tjon Kon Fat; Susan J F van den Eeden; Louis Wilson; Moises Batista da Silva; Claudio G Salgado; John S Spencer; Paul L A M Corstjens; Annemieke Geluk
Journal:  Sci Rep       Date:  2017-08-21       Impact factor: 4.379

5.  Africa-wide evaluation of host biomarkers in QuantiFERON supernatants for the diagnosis of pulmonary tuberculosis.

Authors:  Novel N Chegou; Jayne S Sutherland; Anna-Ritah Namuganga; Paul Lam Corstjens; Annemieke Geluk; Gebremedhin Gebremichael; Joseph Mendy; Stephanus Malherbe; Kim Stanley; Gian D van der Spuy; Magdalena Kriel; Andre G Loxton; Belinda Kriel; Felanji Simukonda; Yonas Bekele; Jacob A Sheehama; Josefina Nelongo; Marieta van der Vyver; Atsbeha Gebrexabher; Habteyes Hailu; Maria M Esterhuyse; Ida Rosenkrands; Claus Aagard; Martin Kidd; Desta Kassa; Adane Mihret; Rawleigh Howe; Jacqueline M Cliff; Amelia C Crampin; Harriet Mayanja-Kizza; Stefan H E Kaufmann; Hazel M Dockrell; Tom H M Ottenhoff; Gerhard Walzl
Journal:  Sci Rep       Date:  2018-02-08       Impact factor: 4.379

6.  Potential of Host Serum Protein Biomarkers in the Diagnosis of Tuberculous Meningitis in Children.

Authors:  Charles M Manyelo; Regan S Solomons; Candice I Snyders; Hygon Mutavhatsindi; Portia M Manngo; Kim Stanley; Gerhard Walzl; Novel N Chegou
Journal:  Front Pediatr       Date:  2019-09-25       Impact factor: 3.418

7.  IP-10 dried blood spots assay monitoring treatment efficacy in extrapulmonary tuberculosis in a low-resource setting.

Authors:  Ida Marie Hoel; Melissa Davidsen Jørstad; Msafiri Marijani; Morten Ruhwald; Tehmina Mustafa; Anne Ma Dyrhol-Riise
Journal:  Sci Rep       Date:  2019-03-07       Impact factor: 4.379

8.  Application of Cerebrospinal Fluid Host Protein Biosignatures in the Diagnosis of Tuberculous Meningitis in Children from a High Burden Setting.

Authors:  Charles M Manyelo; Regan S Solomons; Candice I Snyders; Portia M Manngo; Hygon Mutavhatsindi; Belinda Kriel; Kim Stanley; Gerhard Walzl; Novel N Chegou
Journal:  Mediators Inflamm       Date:  2019-04-16       Impact factor: 4.711

9.  Suitability of saliva for Tuberculosis diagnosis: comparing with serum.

Authors:  Anna Ritah Namuganga; Novel N Chegou; Paul Mubiri; Gerhard Walzl; Harriet Mayanja-Kizza
Journal:  BMC Infect Dis       Date:  2017-08-31       Impact factor: 3.090

10.  "Tuberculosis in advanced HIV infection is associated with increased expression of IFNγ and its downstream targets".

Authors:  Sheetal Verma; Peicheng Du; Damalie Nakanjako; Sabine Hermans; Jessica Briggs; Lydia Nakiyingi; Jerrold J Ellner; Yukari C Manabe; Padmini Salgame
Journal:  BMC Infect Dis       Date:  2018-05-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.